Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 4/20 | 0.68 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.60 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.60 |
| ▸ | MEN1 | O00255 | 1/20 | 0.60 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.60 |
| ▸ | TSHR | P16473 | 1/20 | 0.60 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.55 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.46 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.45 |
| ▸ | SPHK1 | Q9NYA1 | 2/20 | 0.45 |
| ▸ | GMNN | O75496 | 1/20 | 0.45 |
| ▸ | POLB | P06746 | 1/20 | 0.45 |
| ▸ | THPO | P40225 | 1/20 | 0.45 |
| ▸ | MTOR | P42345 | 1/20 | 0.45 |
| ▸ | BLM | P54132 | 1/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.45 |
| ▸ | TP53 | P04637 | 1/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9438396 | 1.00 | LMNA (0.68) | LMNAALDH1A1HSD17B10MEN1KMT2A | |
| SCHEMBL9438313 | 1.00 | LMNA (0.68) | LMNAALDH1A1HSD17B10MEN1KMT2A | |
| SCHEMBL9438215 | 1.00 | LMNA (0.68) | LMNAALDH1A1HSD17B10MEN1KMT2A | |
| SCHEMBL11675408 | 1.00 | LMNA (0.68) | LMNAALDH1A1HSD17B10MEN1KMT2A | |
| SCHEMBL9438222 | 1.00 | LMNA (0.68) | LMNAALDH1A1HSD17B10MEN1KMT2A | |
| SCHEMBL20943375 | 1.00 | LMNA (0.68) | LMNAALDH1A1HSD17B10MEN1KMT2A | |
| SCHEMBL15478664 | 1.00 | LMNA (0.68) | LMNAALDH1A1HSD17B10MEN1KMT2A | |
| SCHEMBL15478680 | 1.00 | LMNA (0.68) | LMNAALDH1A1HSD17B10MEN1KMT2A | |
| SCHEMBL20943378 | 1.00 | LMNA (0.68) | LMNAALDH1A1HSD17B10MEN1KMT2A | |
| SCHEMBL9644075 | 1.00 | LMNA (0.68) | LMNAALDH1A1HSD17B10MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3478277-B1 | ANTI-ACNE COMPOSITIONS AND METHODS OF USE | OREAL (FR) | 2021-06-23 | — | — | EP | claimed |
| EP-2640345-B1 | IMPROVEMENT OF THE APPEARANCE OF FACIAL PORES | PROCTER & GAMBLE (US) | 2018-03-28 | — | — | EP | claimed |
| EP-2640347-B1 | IMPROVEMENT OF THE APPEARANCE OF FINE LINES AND WRINKLES | PROCTER & GAMBLE (US) | 2018-03-21 | — | — | EP | claimed |
| EP-1834628-B1 | Cosmetic composition comprising phytosterols, isoflavones and methylricinoleate, use as inhibitor of 5-alpha-reductase and hair growth | FIRST S P A (IT) | 2010-12-29 | — | — | EP | claimed |
| EP-0521562-B1 | Vesicles in non-polar media | YAMANOUCHI EUROP BV (NL) | 2003-03-05 | — | — | EP | claimed |
| CN-119505367-A | Diisooctyl terephthalate/isononyl/isodecyl ester plasticizer composition, and preparation method and application thereof | 珠海市拾月新材料有限公司 | 2025-02-25 | — | — | CN | disclosed |
| CN-119431888-A | Isooctyl pyromellitate/isononyl isodecyl ester plasticizer composition, and preparation method and application thereof | 珠海市拾月新材料有限公司 | 2025-02-14 | — | — | CN | disclosed |
| US-20250049948-A1 | NOVEL IONIZABLE LIPIDS AND LIPID NANOPARTICLES AND METHODS OF USING THE SAME | SAIL BIOMEDICINES, INC. | 2025-02-13 | — | — | US | disclosed |
| CN-118829625-A | Novel ionizable lipids and lipid nanoparticles and methods of use thereof | 赛欧生物医药股份有限公司 | 2024-10-22 | — | — | CN | disclosed |
| EP-4433450-A1 | NOVEL IONIZABLE LIPIDS AND LIPID NANOPARTICLES AND METHODS OF USING THE SAME | Sail Biomedicines, Inc. (US) | 2024-09-25 | — | — | EP | disclosed |
| WO-2023091490-A1 | NOVEL IONIZABLE LIPIDS AND LIPID NANOPARTICLES AND METHODS OF USING THE SAME | SENDA BIOSCIENCES, INC. (US) | 2023-05-25 | — | — | WO | disclosed |
| US-20170267685-A1 | HETEROARYL COMPOUNDS AND USES THEREOF | BRISTOL-MYERS SQUIBB COMPANY | 2017-09-21 | — | — | US | disclosed |
| EP-0521562-B1 | Vesicles in non-polar media | YAMANOUCHI EUROP BV (NL) | 2003-03-05 | — | — | EP | disclosed |
| EP-1092422-B1 | Composition, particularly for cosmetics containing a sapogenin | OREAL (FR) | 2002-06-26 | — | — | EP | disclosed |
| WO-2002002498-A1 | METHOD FOR PRODUCING A NON-FATTY SOFTENER BASED ON WAX-ESTERS | SOPHIM (FR) | 2002-01-10 | — | — | WO | disclosed |
| EP-1092422-A1 | Composition, particularly for cosmetics containing a sapogenin | L'OREAL (FR) | 2001-04-18 | — | — | EP | disclosed |
| EP-1050296-A1 | Composition containing at least a bicyclic aromatic compound and at least a lipopholic sunscreen, and its uses | L'OREAL (FR) | 2000-11-08 | — | — | EP | disclosed |
| EP-1018540-A1 | Process for preparing a non-fat emollient from olive extracts | Sophim (FR) | 2000-07-12 | — | — | EP | disclosed |
| EP-0521562-A1 | Vesicles in non-polar media | YAMANOUCHI EUROPE B.V. (NL) | 1993-01-07 | — | — | EP | disclosed |
| WO-1993000069-A1 | VESICLES IN NON-POLAR MEDIA | BROCADES PHARMA B.V. (NL) | 1993-01-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170267685-A1 | HETEROARYL COMPOUNDS AND USES THEREOF | PRKACA, PRKDC, AURKC | LMNA 3640/4885ALDH1A1 3719/4885HSD17B10 2993/4885 |
| US-20250049948-A1 | NOVEL IONIZABLE LIPIDS AND LIPID NANOPARTICLES AND METHODS OF USING THE SAME | NPC1L1, ABCB4, LIPA | LMNA 1745/4885ALDH1A1 4108/4885HSD17B10 1780/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.